Lexaria Announces 2021 Annual Meeting Results
Kelowna, British Columbia – TheNewswire – June 29, 2021 – Lexaria Bioscience Corp. (NASDAQ:LXX) (the “Company” or “Lexaria”),…
Lexaria’s DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus
Lexaria Bioscience Corp.(NASDAQ:LEXX) (NASDAQ:LEXXW)(CSE:LXX)(the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that remdesivir and ebastine processed with
Lexaria’s DehydraTECHTM Drug Delivery Technology Is Investigating Applications in Multiple Markets Valued Over USD $100 Billion
Developing a safe and effective drug is important, but it’s only part of the picture.
Lexaria Awards Stock Options
Kelowna, British Columbia – TheNewswire – April 26, 2021 – Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (CSE:LXX) (CSE:LXX)…